Literature DB >> 24617225

[Clinical observation on acupuncture for diarrhea-predominant irritable bowel syndrome patients in syndrome of liver-stagnation and spleen-deficiency and its impact on Th1/Th2].

Xiao-Liang Wu, Ye-Lin Wang, Jian-Hua Sun, Yan-Ye Shu, Li-Xia Pei, Jun-Ling Zhou, Dong Chen, Ji-Wei Zhang, Dao-Wei Zhan.   

Abstract

OBJECTIVE: To observe clinical therapeutic effects of acupuncture for pattern of liver-stagnation and spleen-deficiency in diarrhea-predominant irritable bowel syndrome (D-IBS) and its impact on cell factors.
METHODS: Forty cases were selected and divided into an acupuncture group (21 cases) in which acupuncture was applied and a medicine group (19 cases) in which oral administration of dicetel and bifidobacterium lactobacillus triple viable capsules were applied. The symptom scores, level of Th1-type cytokine (IFN-gamma, IL-2) and Th2-type cytokine (IL-4, IL-10) and ratio of IFN-gamma to IL-4 were compared in two groups before and after treatment to analyze acupuncture effect.
RESULTS: The clinical symptoms were improved after one-week treatment in the acupuncture group (P<0.05), which had faster onset than the medicine group (P<0.05). The total effective rate was 90.48% (19/21) in the acupuncture group, which was superior to 78.95% (15/19) in the medicine group (P<0.05). Compared with medicine treatment, imbalanced condition of Th1/Th2 was turning towards the direction of Th2 after acupuncture, indicating a tendency to recover the balance.
CONCLUSION: The clinical efficacy of acupuncture for D-IBS has close relationship with effectively improving balance of Th1/Th2 in patients with liver-stagnation and spleen-deficiency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24617225

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  8 in total

1.  Immune Modulation and Treatment of Human Papilloma Virus-Related Warts with Energetics of Living Systems Acupuncture.

Authors:  Rom Brustin; Martine Toledano; Tal Geffen; Raia Goona; Malka Hochberg; Bilha Kreisberg; Sari Murad; Jacob Pitcovski
Journal:  Med Acupunct       Date:  2017-06-01

Review 2.  Treatment of irritable bowel syndrome in China: a review.

Authors:  Chun-Yan Li; Shu-Chuen Li
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

3.  Acupuncture for functional gastrointestinal disorders: A systematic review and meta-analysis.

Authors:  Xi-Yang Wang; Hao Wang; Yuan-Yuan Guan; Rong-Lin Cai; Guo-Ming Shen
Journal:  J Gastroenterol Hepatol       Date:  2021-08-18       Impact factor: 4.369

Review 4.  Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis.

Authors:  Haizhen Zheng; Rixin Chen; Xiaofeng Zhao; Guanhui Li; Yi Liang; Hao Zhang; Zhenhai Chi
Journal:  Pain Res Manag       Date:  2019-11-11       Impact factor: 3.037

Review 5.  Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis.

Authors:  Jianbo Guo; Xiaoxiao Xing; Jiani Wu; Hui Zhang; Yongen Yun; Zongshi Qin; Qingyong He
Journal:  Neural Plast       Date:  2020-11-22       Impact factor: 3.599

6.  Electroacupuncture and Moxibustion Modulate the BDNF and TrkB Expression in the Colon and Dorsal Root Ganglia of IBS Rats with Visceral Hypersensitivity.

Authors:  Duiyin Jin; Yanan Liu; Siyi Lv; Qin Qi; Mei Li; Yuanyuan Wang; Xiaomei Wang; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-28       Impact factor: 2.629

7.  Effects and Mechanisms of Acupuncture on Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review.

Authors:  Gezhi Zhang; Tao Zhang; Zeng Cao; Zijing Tao; Tianhao Wan; Mengxi Yao; Xiaolan Su; Wei Wei
Journal:  Front Neurosci       Date:  2022-07-15       Impact factor: 5.152

8.  Effectiveness of acupuncture for irritable bowel syndrome: Protocol for a scoping review of systematic reviews and meta-analyses.

Authors:  Yachen Li; Sike Peng; Fangyuan Liang; Suzhen Liu; Jia Li
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.